A fascinating session at the EASD 2022 conference on emerging technologies sheds light on where we are with AID and telemedicine, and what leading researchers in...

diaTribe is excited to bring you additional expanded coverage from the EASD 2022 conference! Hear from leading clinicians and researchers around the world on insights...

A recent research study on open-source AID, a method of insulin delivery used by thousands of people with type 1 diabetes, showed that using open-source AID improved...

Impressive results from a trial for an up-and-coming artificial pancreas showed that users spent an average of 2.6 more hours in range each day compared to non-users –...

El 27 de julio, Dexcom anunció el lanzamiento de la aplicación móvil Dexcom G6 en español, disponible para cualquier persona con un teléfono inteligente. Los usuarios de...

On July 27, Dexcom announced the launch of the Dexcom G6 mobile app in Spanish, available for anyone with a smartphone. Dexcom CGM users can now choose to view their...

Spinal cord stimulators, a type of implantable device, have been researched as a treatment for painful diabetic neuropathy, a complication of diabetes that leads to...

Earlier this week, Dexcom announced its decision to re-submit the software for the much-anticipated G7, pushing back the US launch date until later in 2022. Here’s why...

diaTribe’s Julie Heverly had the opportunity to try the new Tandem mobile app, which allows users to administer insulin boluses directly from their smartphones. Here’s...

Insulet recently announced that the Omnipod 5 automated insulin delivery (AID) system is now fully available to anyone with type 1 diabetes ages 2 and up. Read about...

Automated insulin delivery (AID) systems have helped many people with diabetes improve their glucose management and Time in Range, both during the day and overnight...

An update to Tandem’s t:connect mobile app, which allows users to administer bolus insulin directly from their smartphones, is now available for iOS and Android. To find...

Insulin pens and pumps are two of the most popular choices for insulin delivery. The CeQur Simplicity aims to combine the strengths of both of these technologies.

Vertex Pharmaceuticals announced its intention to acquire the biotechnology company ViaCyte for $320 million in cash, merging two leaders in beta cell replacement...

See if you are eligible to participate in this study looking at whether the One Touch Solutions platform and its associated partner programs can help people better...

Taking a break from your insulin pump or dealing with a pump malfunction can be a stressful experience. Dr. Ananta Addala, an endocrinologist at Stanford University,...

A study looked at diabetes-related hospitalizations in France before and after people started using a FreeStyle Libre continuous glucose monitor (CGM). Results showed...

Positive results from a study of Weight Watchers’ diabetes-tailored program shows reductions in weight, A1C, diabetes distress. Read on to learn more.

Time in range (TIR) is an actionable metric that captures the highs, lows and in-range glucose values that people with diabetes experience each day. Because TIR shows...

Amber Clour, who has type 1 diabetes, is the founder of Diabetes Daily Grind and host of the podcast Real Life Diabetes. She shares her experience attending the 2022...